Analysis and immunogenicity of large biomolecules
- You are working as an analyst or researcher in a (bio) pharmaceutical/biotechnology laboratory
- You have a special interest in synthesis and production of glycoproteins
- You want to expand your knowledge on these specific subjects and related compounds.
- niveau Postbachelor
- duur 2 dagen
- studiebelasting n.v.t. i
- studiekosten € 1.360,-
-
startdata
- 06-12-2017 Breda en 7 december 2017
Analysis and immunogenicity of large biomolecules
Large molecules, such as therapeutic antibodies, are an exponentially growing drug section and the analysis of these molecules in matrix is pivotal to support preclinical and clinical studies. In addition, the safety of large molecules is a major concern for both pharma/biotech and the regulatory authorities. Therefore, immunogenicity testing is also mandatory. Both aspects, bioanalysis and immunogenicity, are introduced in this course with a specialfocus on preclinical assessment with technologies, such as ELISA and LC-MS. Validation and troubleshooting of the assays are also an important part of this course l. Special attention is also given to biosimilars.
- Doelgroep
-
Doelgroep
You are an analyst or researcher in a (bio) pharmaceutical/biotechnology laboratory, working on the analysis of therapeutic antibodies, biosimilars and other (new) bio pharmaceuticals. Research fields of your laboratory can also involve synthesis and production of glycoproteins or related compounds.
- Werkvorm
-
Werkvorm
This course will be a mixture of theoretical background, real-life examples and practical cases. The course will be presented in Dutch.
- Studiebelasting
-
Studiebelasting
This course has a duration of 2 days.
- Studiekosten
-
Studiekosten
The investment of this course will be € 1.360,- (excl. 21% VAT).
You will receive the invoice before the start of the course.
- Diploma
-
Diploma
After this course you will receive a document of participation.
- Resultaat
-
Resultaat
You will be able to understand the practical basics to measure concentrations of a biopharmaceutical in matrix and antibody drug antibodies. In addition, the participant will understand the most recent theoretical basics and importance of bioanalysis and immunogenicity; why it became such important topics; the science behind it; regulatory requirements; how to address them and subsequently lead your product to market approval.
- Contact
-
Contact
Heeft u vragen over deze opleiding? Of kunt u advies gebruiken bij het maken van een keuze? Neem dan vrijblijvend contact op met opleidingsmanager John Hageman via jhageman@avansplus.nl of via 076-5258891.